Diabetes Drug May Slow Parkinson's Disease Diabetes Drug May Slow Parkinson's Disease
Exenatide improved off-medication motor scores in patients with Parkinson ' s disease in a placebo-controlled trial, and the benefits persisted for several weeks after the drug was discontinued.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 14, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

UCL research indicates use of diabetes drug in Parkinson ’s disease
University College London (UCL) has carried out a study that indicated the potential of a common diabetes drug called exenatide as a disease-modifying therapy for treating Parkinson ’s disease. (Source: Drug Development Technology)
Source: Drug Development Technology - August 7, 2017 Category: Pharmaceuticals Source Type: news

Diabetes Drug Shows Promise Against Parkinson's
Byetta improved symptoms of motor disease in small, short trial, but more research needed (Source: WebMD Health)
Source: WebMD Health - August 4, 2017 Category: Consumer Health News Source Type: news

Diabetes drug may be helpful for Parkinson's disease
Conclusion This research shows some interesting early findings, though the magnitude of effect was very small compared to the improvements in symptoms with current dopaminergic drugs. The study was well conducted but did have some limitations: The number of people taking part was quite small. This may have meant it was hard to detect any other benefits or harms of taking the drug other than the effects on motor scores. The period of time people were given the drug and followed up meant that longer-term effects could not be measured. The benefit of the drug observed so far might not be big enough to make a differen...
Source: NHS News Feed - August 4, 2017 Category: Consumer Health News Tags: Neurology Source Type: news

Diabetes Drug Shows Promise Against Parkinson's
Byetta improved symptoms of motor disease in small, short trial, but more research needed Source: HealthDay Related MedlinePlus Pages: Diabetes Medicines, Parkinson's Disease (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - August 4, 2017 Category: Consumer Health News Source Type: news

Medical News Today: Diabetes shot boosts motor function for patients with Parkinson's
A placebo trial shows that the diabetes drug exenatide improved motor symptoms of Parkinson's disease and may have disease-altering potential. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 4, 2017 Category: Consumer Health News Tags: Parkinson's Disease Source Type: news

Diabetes shot boosts motor function for patients with Parkinson's
A placebo trial shows that the diabetes drug exenatide improved motor symptoms of Parkinson's disease and may have disease-altering potential. (Source: Parkinson's Disease News From Medical News Today)
Source: Parkinson's Disease News From Medical News Today - August 4, 2017 Category: Neurology Tags: Parkinson's Disease Source Type: news

Diabetes Drug, Exenatide, Shows Promise Against Parkinson's
FRIDAY, Aug. 4, 2017 -- The diabetes drug exenatide (Byetta) may do double duty as a treatment for Parkinson ' s disease, a new study suggests. " This is a very promising finding, as the drug holds potential to affect the course of the disease itself,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 4, 2017 Category: General Medicine Source Type: news

Diabetes Drug Shows Promise Against Parkinson's
FRIDAY, Aug. 4, 2017 -- The diabetes drug exenatide (Byetta) may do double duty as a treatment for Parkinson ' s disease, a new study suggests. " This is a very promising finding, as the drug holds potential to affect the course of the disease itself,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 4, 2017 Category: General Medicine Source Type: news

Diabetes drug could help those living with Parkinson's disease
A study published inThe Lancet suggests that exenatide improves movement-related issues and might also slow the progression of the disease.The Guardian (Source: Society for Endocrinology)
Source: Society for Endocrinology - August 4, 2017 Category: Endocrinology Source Type: news

Diabetes drug could help those living with Parkinson's disease, research reveals
Study suggests that exenatide, currently used to treat type 2 diabetes, improves movement-related issues and might also slow the progression of the diseaseA drug commonly used to treat diabetes could help those living with Parkinson ’s disease, research has revealed.By 2020 it is predicted that 162,000 individuals in the UK will be living with the condition. While existing drugs help to controlits symptoms, there are currently none available which slow or halt its progression.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - August 4, 2017 Category: Science Authors: Nicola Davis Tags: Medical research Parkinson's disease Diabetes Health Society Science Source Type: news

Diabetes drug could halt Parkinson's progression
Optimistic researchers say exenatide presents 'major new avenue for investigation' Related items fromOnMedica Many people ashamed to admit to Parkinson ’s disease Diabetes drug could protect against Parkinson ’s disease Hepatitis may increase risk of Parkinson's disease (Source: OnMedica Latest News)
Source: OnMedica Latest News - August 4, 2017 Category: UK Health Source Type: news

Type 2 diabetes drug could combat Parkinson's
People with Parkinson ’s who took Exenatide – an existing diabetes medication - for around a year had better motor skills than those who took a placebo. (Source: the Mail online | Health)
Source: the Mail online | Health - August 3, 2017 Category: Consumer Health News Source Type: news

Diabetes drug shows potential as disease-modifying therapy for Parkinson's disease
A drug commonly used to treat diabetes may have disease-modifying potential to treat Parkinson's disease, a new UCL-led study suggests, paving the way for further research to define its efficacy and safety. The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson's Research (MJFF), found that people with Parkinson's who injected themselves each week with exenatide for one year performed better in movement (motor) tests than those who injected a placebo. (Source: World Pharma News)
Source: World Pharma News - August 3, 2017 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news